Researchers are studying a potential new chimeric antigen receptor-T cell therapy (CAR-T cell therapy) treatment for multiple myeloma.
source https://www.sciencedaily.com/releases/2021/06/210625173204.htm
Sunday, 27 June 2021
Related Posts
Stem cells do not (only) play dice
A new tool for studying COVID's impact on gut health
Warming temperatures increasingly alter structure of atmosphere
New insights into the structure of the neutron
Immunotherapy-chemotherapy treatment coupled with in-depth genomic analyses leads to improved survival for patients with mesothelioma
Study offers insights on why the elderly are more susceptible to COVID-19
0 comments: